Medscape Medical News
- FDA Okays New Oral CGRP Antagonist for Migraine Prevention
- Alert FDA Okays Evolocumab Add-On for FH in Children Aged 10 and Up
- Alert FDA Approves Cabozantinib for Differentiated Thyroid Cancer
- Alert FDA Approves Ruxolitinib for Treatment of Chronic GVHD
- Alert FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis
- Alert First AI Pathology Program Approved: Helps Detect Prostate Cancer
- Alert FDA Approval for Tisotumab Vedotin in Advanced Cervical Cancer
- Alert FDA Approves Abbott's Portico Valve for TAVR
- Alert FDA Approves Ranibizumab Biosimilar
- Alert FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion
- Alert FDA Grants Zanubrutinib an Accelerated Approval in MZL
- FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine
- Alert FDA Approval for Zanubrutinib in Waldenström’s Macroglobulinemia
- Alert FDA Approves First Once-Weekly Growth Hormone for Children
- Alert FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia
- Alert FDA OKs IV Briviact for Seizures in Kids as Young as 1 Month
- Alert FDA OKs First Vagus Nerve Stimulation System for Stroke Rehab
- Alert FDA Okays Difelikefalin for Dialysis-Associated Pruritus in CKD
- Alert FDA Approves Ivosidenib for Bile Duct Cancer
- Alert FDA Okays New PAD Indication for Rivaroxaban (Xarelto)